3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Motor Activity
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Fatigue
1
Disease
1
Colonic Neoplasms
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Temozolomide
2
Cyclophosphamide
2
Cisplatin
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Triiodothyronine
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Platinum
1
Pharmacogenomic Variants
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Exercise
×
30 days
×
Clear all
No trials found.